Facial acneiform rash associated with sorafenib.
Sorafenib is an oral multikinase inhibitor that is useful in the treatment of various solid cancer. We report a patient who developed an acneiform facial eruption during treatment with this medication.
Fleta-Asín
Beatriz
B
Dermatology Department, Ramon y Cajal Hospital, University of Alcalá de Henares, Madrid, Spain. beatriz_fleta@hotmail.com
Vañó-Galván
Sergio
S
Ledo-Rodríguez
Alejandro
A
Truchuelo-Díez
Maite
M
Jaén-Olasolo
Pedro
P
D017486:Acneiform Eruptions / Q000139:chemically induced*; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000139:chemically induced*; D017809:Fatal Outcome; D005260:Female; D018323:Hemangioendothelioma, Epithelioid / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000601:surgery; D016031:Liver Transplantation; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011183:Postoperative Complications / Q000139:chemically induced; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases